Form 4 for CMPX Compass Therapeutics, Inc.
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-09 · accession 0001171843-24-006859 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-10 | 2024-12-09 | CMPX | Shin Barry | CFO | A - Grant | $1.65 | +400.0K | 400.0K | New | +$660.0K |
| D | 2024-12-10 | 2024-12-09 | CMPX | Shin Barry | CFO | A - Grant | $0.00 | +400.0K | 400.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | A | A | 400,000 | $1.65 | 400,000 | D | — | — | (F1) Represents restricted stock units ("RSU") granted to the reporting person on December 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vesting on December 9, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-09 | A | A | 400,000 | $0.00 | 400,000 | D | $1.65 · — to 2034-12-09 | 400,000 Common Stock | (F2) The options vest as follows: 25% on December 9, 2025, with the remaining over 36 substantially equal monthly installments starting January 9, 2026. |